Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05602610

Clinical Prognostic Score to Predict Relapse in VL

Sponsor: Institute of Tropical Medicine, Belgium

View on ClinicalTrials.gov

Summary

This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia. Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.

Official title: Comprehensive Clinical and Laboratory Assessment of Visceral Leishmaniasis to Develop Clinical Prognostic Tools to Predict Relapse: a Prospective Cohort Study in Ethiopia

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

OBSERVATIONAL

Enrollment

741

Start Date

2023-02-03

Completion Date

2027-06-30

Last Updated

2024-03-05

Healthy Volunteers

No

Interventions

OTHER

No intervention

No intervention

Locations (1)

University of Gondar

Gonder, Ethiopia